MedPath

The Effect of MDZ on Movement During UIA Clipping

Phase 4
Recruiting
Conditions
Intraoperative Movement
Interventions
Drug: Normal saline
Registration Number
NCT05553678
Lead Sponsor
Seoul National University Hospital
Brief Summary

This study is a randomized, controlled, double-blinded, and parallel design study. A total 64 patients will be randomized to receive midazolam or normal saline during unruptured intracranial aneurysm clipping surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Patients who undergo elective unruptured intracranial aneurysm clipping surgery
  • American Society of Anesthesiologists grade 1,2,3
  • age > 18 year old
Exclusion Criteria
  • Refuse to participate to the study
  • Body Mass Index < 18.5 kg/m2 or > 35 kg/m2
  • Allergic history of benzodiazepine
  • Pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupNormal salineNormal saline (0.03 ml/kg/30 min) will administered during UIA clipping through microscope.
treatment groupMidazolamMidazolam (0.03 mg/kg/30 min) will administered during UIA clipping through microscope.
Primary Outcome Measures
NameTimeMethod
Intraoperative movementDuring microscopic surgery

Incidence

Secondary Outcome Measures
NameTimeMethod
Motor evoked potential amplitudeimmediately postoperative surgery

amplitude

Satisfaction score for intraoperative environmentimmediately postoperative surgery

using 11-point score (0=worst dissatisfied, 10=very sattisfied)

Motor evoked potential Latencyimmediately postoperative surgery

Latency

Duration of ICU stayFrom date of ICU admission until the date of first discharge from ICU, assessed up to 1 week

duration of ICU stay, day

Duration of mechanical ventilation timeEnd of surgery to extubation time

duration

Postoperative deliriumPostoperative 24 hour

Incidence

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath